CF Foundation | Trikafta Approved for Ages 6 Through 11

Published on augustus 17, 2021 by

In June 2021, the @U.S. Food and Drug Administration approved the use of Trikafta® for children with cystic fibrosis ages 6 through 11 years old with certain mutations. This is an exciting milestone for many in the CF community, but especially for those with young children with CF who can now benefit from a modulator for the first time.

Read the news story:


Add your comment

Your email address will not be published.